First-trimester free beta (hCG) screening for Down syndrome

Maternal serum free beta (hCG) levels are elevated (median 2·20 MOM) in the first trimester of pregnancy in 38 Down syndrome cases as compared with appropriate controls. This observation may form the basis for its use as a marker in screening for Down syndrome in the first trimester. Altered levels of the free beta analyte are observed in pregnancy conditions or complications other than Down syndrome.     

First Detection of Hepatitis E Virus in Shellfish and in Seawater from Production Areas in Southern Italy

Shellfish samples (n = 384) from production areas, water samples from the same areas (n = 39) and from nearby sewage discharge points (n = 29) were analyzed for hepatitis E virus (HEV) by real-time and nested RT-PCR. Ten shellfish samples (2.6%) and five seawater samples (12.8%) tested positive for HEV; all characterized strains were G3 and showed high degree of sequence identity. An integrated surveillance in seafood and waters is relevant to reduce the risk of shellfish-associated illnesses.     

Ethical issues associated with prenatal screening using non-invasive prenatal testing for sex chromosome aneuploidy

Prenatal screening for sex chromosome aneuploidies (SCAs) is increasingly available through expanded non-invasive prenatal testing (NIPT). NIPT for SCAs raises complex ethical issues for clinical providers, prospective parents and future children. This paper discusses the ethical issues that arise around NIPT for SCAs and current guidelines and protocols for management. The first section outlines current practice and the limitations of NIPT for SCAs. It then outlines key guidelines before discussing the ethical issues raised by this use of NIPT. We conclude that while screening for SCAs should be made available for people seeking to use NIPT, its implementation requires careful consideration of what, when and how information is provided to users.     

Wasteload Allocation Using Wastewater Treatment and Flow Augmentation

A Wasteload allocation model, named Cost-Flow-Augmentation Model involving wastewater treatment and flow augmentation as a method of pollution abatement has been developed. The cost functions for wastewater treatment were developed as power functions of biochemical oxygen demand (BOD) removal using the regression module of the SPSS10 software. The cost function for flow augmentation was also developed using a regression between cost of dam/barrage and corresponding flow released from upstream reservoir for downstream water quality improvement. The response of wasteloads and flow augmentation on the water quality was quantified in terms of transfer coefficient calculated using the QUAL2E water quality simulation model. The performance of these models is demonstrated on the 22-km-long Delhi stretch of river Yamuna, India. Optimal solutions of the formulated models were obtained using the Web-based interactive non-differentiable interactive multiobjective bundle-based optimization system software. The optimal solutions obtained reveal that flow augmentation is not an economically feasible pollution abatement option for the Delhi stretch of river Yamuna.